Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database

Figure 7

Decision curve analysis for the nomograms and histologic type of validation set. Figure (a) and (c) are the new benefit curves of 3- and 5-year OS rates of validation set. Figures (b) and (d) are the net reduction for intervention curves of the 3- and 5-year OS rates of the validation set. Figure (e) and (g) are the new benefit curves of 3- and 5-year CSS rates of validation set. Figures (f) and (h) are the net reduction for intervention curves of the 3- and 5-year CSS rates of the validation set.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)